Regulations.gov document
Guidance for Industry on Immunogenicity-Related Considerations for Low Molecular Weight…
Notice · FDA-2014-D-0310 · posted Feb 19, 2016
Key facts
| Document ID | FDA-2014-D-0310-0007 |
|---|---|
| Title | Guidance for Industry on Immunogenicity-Related Considerations for Low Molecular Weight Heparin; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2014-D-0310 |
| Posted | Feb 19, 2016 |
| Federal Register citation | 81 FR 8501 |
| FR document number | 2016-03461 |
| Comment period opens | Feb 19, 2016 |
| Effective date | Feb 19, 2016 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: